Because decreased TP63 levels have been associated with enhanced invasion and migration as well as metastatic potential of cancer cells [37–39], we hypothesized that, upon IL13Rα2 knockdown, IL-13 signaling suppresses metastasis by impairing the ability of breast cancer cells to migrate. Here, IL13 is linked to breast carcinoma.